contrary role in angiogenesis. Netrin4 suppresses VEGF-stimulated endothelial cell migration and tube formation by binding to the transmembrane receptor Neogenin (Neo1). 7 Elevated NTN4 also decreases pancreatic and colorectal cancer growth by inhibiting tumour angiogenesis. 8, 9 In the corneal mouse model, Ntn4
inhibits suture-mediated neovascularization. 10 Whether NTN4
acts as a pro-or anti-angiogenic factor may be context dependent. Here, we report that NTN4 is a target of Notch signalling, a conserved pathway which is important in both embryonic and disease-related angiogenesis.
Notch signalling is highly conserved between species and is critical for differentiation, proliferation and fate determi- 
| MATERIAL S AND ME THODS

| Animals
The generation of the endothelial-specific NICD1 Tg mice has been previously described. 14, 15 All animal experiments were approved by the Ethics Committee of Shandong Provincial Qianfoshan Hospital. 
| Cell culture and transduction
| Chromatin immunoprecipitation assay
| Dual-luciferase reporter assay
Human NTN4 promoter fragments were amplified from human gDNA through polymerase chain reaction (Fermentas, Waltham, MA). The fragments were subcloned into the pGL3-basic plasmid through Xho I/Hind III digestion. Primer sequences are disclosed in supporting materials (Table S1 ). Promoter fragments were subcloned into the (Table S1 ).
| Statistical analysis
All quantitative results were calculated from at least three independent experiments. Values represented means ± standard error.
Student's t test was utilized for statistical analysis.
| RE SULTS AND D ISCUSS I ON
| Activation of Notch signalling increases NTN4 expression
Both Figure S4A ,B) and NICD1 production ( Figure S4B ).
Transcription of the NTN4 gene ( Figure S4A ), cellular ( Figure S4B ) and secreted NTN4 protein level ( Figure S4C ) was significantly increased.
Moreover, dibenzazepine (DBZ), a specific inhibitor of γ-secretase and Notch signalling, dramatically reduced the expression of HES1
( Figure S5A ,B) and the production of NICD1 ( Figure S5B ) in HUVECs.
Consequently, transcription of the NTN4 gene ( Figure S5A ), cellular ( Figure S5B) and secreted NTN4 protein level ( Figure S5C ) was markedly decreased in DBZ-treated HUVECs. These results imply that NTN4 lies downstream of Notch signalling. We next asked whether NTN4 involves in Notch signalling-regulated angiogenic activities.
The expression of NTN4 in NICD1-overexpressing HUVECs was down-regulated by NTN4 siRNAs ( Figure S6A ). As shown in Figure   S6B and C, NTN4 knockdown moderately rescues Notch1 activationinduced reduction of proliferation and migration of HUVECs. The results are consistent with previous studies showing anti-angiogenic effects of NTN4 in endothelial cells. 7, 10 Together, our study suggests that NTN4 is a member of Notch1-targeted gene network in regulation of angiogenesis.
| The −53 TGGGAA promoter element is essential for Notch-induced NTN4 transcription
We examined the NTN4 promoter for sequence that might mediate transactivation downstream of Notch. We found that the F I G U R E 2 A −53 bp TGGGAA element in the NTN4 promoter is essential for Notch transactivation. A, Human NTN4 promoter fragments inserted into reporter plasmids for this study. (B,C) Reporter plasmids were transfected into human umbilical vein endothelial cells (HUVECs). Basal activity of corresponding fragments was monitored by dual-luciferase reporter (DLR) assay. D, The Fragment 3 wildtype and mutant plasmids were cotransfected into HUVECs expressing Notch1 intracellular domain (NICD1). The transcriptional activity was monitored by DLR assay. E, The binding of CSL to the −53 bp element of the NTN4 promoter was detected by ChIP assay. CSL antibody was used to pulldown CSL. IgG was used as negative control for ChIP. F, The binding of NICD1 protein to the −53 bp element of the NTN4 promoter was monitored by ChIP assay. The quantitative analysis of band intensity was normalized to the input. *P < 0.05; **P < 0.01; ns, no significance; M, marker. FL, full length CSL-preferred binding element, TGG/TGAA, occurred at three unique sites in the NTN4 promoter ( Figure 2A ) and sought to determine which, if any, functioned to regulate basal activation of the reporter. We constructed a series of DLR assay plasmids that contained at least one of these predicted binding sites (Figure 2A ; Figure S7 ). The DLR assay in HUVECs showed that ablation of the sequence from −233 bp to +388 bp, which contained a predicted CSL site at −53 bp, had a drastic effect on the transcription activation of the NTN4 promoter plasmid ( Figure 2B ). Ablation of other fragments failed to alter the reporter activity. To validate that it was the −53 bp CSL-binding site that played an important role in activating the NTN4 reporter plasmid, we created a mutant that contained five nucleotide substitutions at the −53 binding site (TGGGAA to GTGTCC) (Figure 2A) . Deletion of the CSL-binding site lead to a more than 60% decrease in basal transcriptional activity ( Figure 2C ).
Next we evaluated the role of Notch signalling in transcriptional activation. As shown in Figure 2D 
ACK N OWLED G EM ENTS
This study is supported by grants from the National Natural Science 
CO N FLI C T O F I NTE R E S T
All the authors declared no conflict of interest.
AUTH O R S' CO NTR I B UTI O N S
JL designed the research study; CL, JL contributed essential reagents or tools; QL WS, JL, YW, TA performed the experiments and analysed the data; QL CL, TA, JL wrote the paper. All the authors read and approved the manuscript.
O RCI D
Ju Liu
https://orcid.org/0000-0001-9932-2613
